Themis Medicare Limited (THEMISMED) has submitted an investor presentation notification to the NSE exchange. Details of the presentation materials remain to be disclosed.
Themis Medicare Limited informed the NSE about an investor presentation, signaling potential communication to shareholders and institutional investors regarding company performance and outlook.
Themis Medicare has issued a corporate announcement directing investors to its Q4 FY2026 investor presentation filed with BSE. The filing relates to the quarter ended March 31, 2026.
Themis Medicare has filed its Q4 FY2026 investor presentation on the Bombay Stock Exchange, covering the quarter ended March 31, 2026.
Themis Medicare's board has approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026, while recommending a final dividend of 50 paise per share.
Themis Medicare Limited has submitted its Q4 FY2025-26 financial results to NSE, marking the close of the fiscal year reporting cycle. Market participants are watching for further disclosure of operational metrics.
THEMIS MEDICARE Q3 FY25 Results
THEMIS MEDICARE Q2 FY25 Results
THEMIS MEDICARE Q3 FY24 Results
NSE & BSE filings, earnings, insider trades, and smart volume alerts — on WhatsApp or Telegram. No separate app to install.